Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Panic disorder: a biological perspective.

R S Kahn1, H M van Praag

  • 1Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029.

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|March 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CENTRAL SEROTONIN DEFICIENCY-A FACTOR WHICH INCREASES DEPRESSION VULNERABILITY?

Acta psychiatrica Scandinavica·2017
Same author

On holy cows and golden calves.

Acta neuropsychiatrica·2016
Same author

The role of serotonin in Parkinsons' Disease: An integrated approach for research of motor, cognitive and affective symptoms with functional intervention studies.

Acta neuropsychiatrica·2016
Same author

Anchorpoints: an introspective.

Acta neuropsychiatrica·2016
Same author

Biological psychiatry marching towards the future and the perils of progress.

Acta neuropsychiatrica·2016
Same author

Cardiological risk factors for depressive symptoms after a first myocardial infarction.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2015
Same journal

Commentary on: The American Society of Clinical Psychopharmacology task force consensus statement on the deprescribing of stimulant medications in adults with ADHD.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
Same journal

Corrigendum to "Functioning assessment short test for autism (FAST-A): a tool to evaluate adaptive functioning in autistic adults" [European Neuropsychopharmacology, 112, 112887].

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
Same journal

Genomic relationship between polyendocrine metabolic ovarian syndrome and bipolar disorder.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
Same journal

Genetic overlap between depression and C-reactive protein levels: Evidence from a cross-trait analysis.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
Same journal

Variability in AI-generated psychedelic definitions across major chatbots.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
Same journal

In-patient treatment and structural dysconnectivity in major depression - A longitudinal connectome study.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
See all related articles

Panic disorder (PD), a prevalent psychiatric condition, is treatable with medications like antidepressants and benzodiazepines. Biological overlaps with other disorders and its exact cause remain under investigation.

Area of Science:

  • Psychiatry
  • Neuroscience
  • Pharmacology

Background:

  • Panic disorder (PD) recognized as distinct 25 years ago.
  • PD is prevalent and responds to antidepressants and benzodiazepines.
  • Clinical overlap exists between PD, GAD, and MDD, but biological overlap is unclear.

Purpose of the Study:

  • To explore the biological underpinnings of panic disorder.
  • To investigate potential biological overlaps between PD and other psychiatric conditions.
  • To review current theories and future research directions for PD pathogenesis.

Main Methods:

  • Review of existing literature on PD.
  • Discussion of preliminary theories on CO2 sensitivity and serotonin.
  • Consideration of alpha 2-adrenergic dysregulation in PD.

Related Experiment Videos

  • Highlighting the potential of novel pharmacological agents and imaging techniques.

    • Main Results:

    • PD is a well-defined, treatable disorder.
    • Biological links between PD and other psychiatric disorders are not yet established.
    • Current theories regarding PD pathogenesis (CO2, serotonin, alpha 2-adrenergic) are preliminary or unproven.

    Conclusions:

    • Further research is needed to clarify the biological basis of PD.
    • Development of selective receptor agonists/antagonists and advanced imaging may elucidate PD pathogenesis.
    • Understanding biological overlaps could refine diagnostic criteria and treatment strategies for PD.